Triple Negative Breast Cancer and Celecoxib. Pilot Study

Clinical trial NCT07104266 · RECRUITING

Trial details

NCT number: NCT07104266
Sponsor: Université de Sherbrooke
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-Negative Breast Cancer

Start date: 2025-08-04
Primary completion: 2028-08-04
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.